Inventor · disambiguated record
Eric A. Tanifum
Also filed as: TANIFUM ERIC · TANIFUM ERIC A
12 granted patents·9 pending applications·7 citations·filing 2012–2025
83Inventor score
Files withTexas Childrens Hospital12ALZECA BIOSCIENCES LLC2ANNAPRAGADA ANANTH2BAYLOR COLLEGE MEDICINE1BOARD OF REGENTS OF THE UNIV OF HOUSTON SYSTEM1
Top patents by PatentIndex Score
21 records- 0183US9744251B2MRI imaging of amyloid plaque using liposomesTEXAS CHILDREN'S HOSPITAL·Filed 2015·Granted Aug 29, 2017·2 cites·15 claims
- 0277US8679531B2Vesicle compositionsANNAPRAGADA ANANTH·Filed 2012·Granted Mar 25, 2014·5 cites·17 claims
- 0371US2020069820A1Mri imaging of amyloid plaque using liposomesTexas Childrens Hospital·Filed 2019·Application pending·0 cites
- 0468US11141495B2MRI imaging of amyloid plaque using liposomesTexas Childrens Hospital·Filed 2020·Granted Oct 12, 2021·0 cites·20 claims
- 0568US2025281652A1Targeted contrast agents for mri of amyloid depositionTexas Childrens Hospital·Filed 2025·Application pending·0 cites
- 0664US11116854B2Targeted contrast agents for MRI of amyloid depositionTexas Childrens Hospital·Filed 2021·Granted Sep 14, 2021·0 cites·18 claims
- 0764US10537649B2MRI imaging of amyloid plaque using liposomesTexas Childrens Hospital·Filed 2016·Granted Jan 21, 2020·0 cites·18 claims
- 0864US2023398238A1Targeted contrast agents for mri of alpha-synuclein depositionTexas Childrens Hospital·Filed 2023·Application pending·0 cites
- 0963US11779664B2Targeted contrast agents for MRI of alpha-synuclein depositionTexas Childrens Hospital·Filed 2022·Granted Oct 10, 2023·0 cites·11 claims
- 1062US2022023445A1Targeted contrast agents for mri of amyloid depositionTexas Childrens Hospital·Filed 2021·Application pending·0 cites
- 1159US2024165273A1Self-assembling molecules enabling high performance in vivo imaging in the second near infrared (nir-ii) windowBAYLOR COLLEGE MEDICINE·Filed 2023·Application pending·0 cites
- 1252US2023136718A1Functionalized liposomes for imaging misfolded proteinsALZECA BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 1349US11241510B2Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR signaturesTexas Childrens Hospital·Filed 2017·Granted Feb 8, 2022·0 cites·10 claims
- 1447US10124078B2Lipid-based nanoparticlesBOARD OF REGENTS OF THE UNIV OF HOUSTON SYSTEM·Filed 2017·Granted Nov 13, 2018·0 cites·20 claims
- 1547US2021170055A1Targeted contrast agents for mri of amyloid depositionTexas Childrens Hospital·Filed 2021·Application pending·0 cites
- 1646US11052162B2Liposomal gadolinium (GD) contrast agent “NMRX” for T1-MRITexas Childrens Hospital·Filed 2017·Granted Jul 6, 2021·0 cites·19 claims
- 1746US9801957B2Lipid-based nanoparticlesANNAPRAGADA ANANTH·Filed 2012·Granted Oct 31, 2017·0 cites·12 claims
- 1845US2021252170A1Targeted contrast agents for mri of alpha-synuclein depositionTexas Childrens Hospital·Filed 2021·Application pending·0 cites
- 1943US9278068B2Vesicle compositionsSENSULIN LLC·Filed 2014·Granted Mar 8, 2016·0 cites·23 claims
- 2040US11312685B2Targeting nanoparticlesTEXAS CHILDRENS HOSPTIAL·Filed 2018·Granted Apr 26, 2022·0 cites·56 claims
- 2140US2020261605A1Functionalized liposomes for imaging misfolded proteinsALZECA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →